1 – 10 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
RNA in Stow, Leukemia on the Go : P-Bodies RNA Sequestration Drives Leukemogenesis
- Contribution to journal › Article
-
Mark
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
- Contribution to journal › Article
-
Mark
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population-Based Study
- Contribution to journal › Article
-
Mark
Understanding the characteristic behaviour of the wild-type and mutant structure of FLT3 protein by computational methods
- Contribution to journal › Article
- 2024
-
Mark
Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia
- Contribution to journal › Article
- 2023
-
Mark
Genome-wide analysis of KMT2A-rearranged leukemia
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
- Contribution to journal › Article
- 2022
-
Mark
The Opportunity of Proteomics to Advance the Understanding of Intra- and Extracellular Regulation of Malignant Hematopoiesis
- Contribution to journal › Scientific review
-
Mark
Small Molecule Screening of Primary Human Acute Myeloid Leukemia Using Co-culture and Multiplexed FACS Analysis
- Contribution to journal › Article
-
Mark
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia
- Contribution to journal › Article
